CD81 | CD81 molecule | CD markers Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
CD82 | CD82 molecule | Cancer-related genes CD markers Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
CD83 | CD83 molecule | CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
CD84 | CD84 molecule | CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
CD86 | CD86 molecule | CD markers FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
CD8A | CD8a molecule | CD markers Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD8B | CD8b molecule | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD9 | CD9 molecule | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
CD93 | CD93 molecule | CD markers Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
CD96 | CD96 molecule | CD markers Disease related genes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CD97 | CD97 molecule | CD markers G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
CD99 | CD99 molecule | CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CDCP1 | CUB domain containing protein 1 | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
CDH1 | Cadherin 1, type 1, E-cadherin (epithelial) | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
CDH2 | Cadherin 2, type 1, N-cadherin (neuronal) | CD markers Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CDH5 | Cadherin 5, type 2 (vascular endothelium) | Cancer-related genes CD markers Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CEACAM1 | Carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) | CD markers Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CEACAM3 | Carcinoembryonic antigen-related cell adhesion molecule 3 | CD markers Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
CEACAM5 | Carcinoembryonic antigen-related cell adhesion molecule 5 | Cancer-related genes CD markers Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CEACAM6 | Carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen) | Cancer-related genes CD markers Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
CEACAM8 | Carcinoembryonic antigen-related cell adhesion molecule 8 | CD markers Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
CLEC10A | C-type lectin domain family 10, member A | CD markers Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
CLEC4C | C-type lectin domain family 4, member C | CD markers Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CLEC4M | C-type lectin domain family 4, member M | CD markers Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
CR1 | Complement component (3b/4b) receptor 1 (Knops blood group) | Blood group antigen proteins CD markers Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CR2 | Complement component (3d/Epstein Barr virus) receptor 2 | CD markers Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
CRTAM | Cytotoxic and regulatory T cell molecule | CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
CSF1R | Colony stimulating factor 1 receptor | Cancer-related genes CD markers Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Mixed |
CSF2RA | Colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) | Cancer-related genes CD markers Disease related genes FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CSF2RB | Colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) | CD markers Disease related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CSF3R | Colony stimulating factor 3 receptor (granulocyte) | Cancer-related genes CD markers Disease related genes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CTLA4 | Cytotoxic T-lymphocyte-associated protein 4 | CD markers Disease related genes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CXCR1 | Chemokine (C-X-C motif) receptor 1 | Cancer-related genes CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
CXCR2 | Chemokine (C-X-C motif) receptor 2 | Cancer-related genes CD markers G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CXCR3 | Chemokine (C-X-C motif) receptor 3 | CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
CXCR4 | Chemokine (C-X-C motif) receptor 4 | Cancer-related genes CD markers Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Expressed in all |
CXCR5 | Chemokine (C-X-C motif) receptor 5 | CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
CXCR6 | Chemokine (C-X-C motif) receptor 6 | CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |
DDR1 | Discoidin domain receptor tyrosine kinase 1 | CD markers Enzymes Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
DDR2 | Discoidin domain receptor tyrosine kinase 2 | CD markers Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
DPP4 | Dipeptidyl-peptidase 4 | CD markers Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
EMR2 | Egf-like module containing, mucin-like, hormone receptor-like 2 | CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
ENG | Endoglin | Cancer-related genes Candidate cardiovascular disease genes CD markers Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
ENPEP | Glutamyl aminopeptidase (aminopeptidase A) | CD markers Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
ENPP1 | Ectonucleotide pyrophosphatase/phosphodiesterase 1 | CD markers Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
ENPP3 | Ectonucleotide pyrophosphatase/phosphodiesterase 3 | CD markers Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
ENTPD1 | Ectonucleoside triphosphate diphosphohydrolase 1 | CD markers Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Mixed |
EPCAM | Epithelial cell adhesion molecule | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ERBB2 | V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
EVI2B | Ecotropic viral integration site 2B | CD markers Predicted membrane proteins
| | | | | Mixed |